GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · IEX Real-Time Price · USD
0.283
-0.001 (-0.39%)
Jul 22, 2024, 10:16 AM EDT - Market open
GlycoMimetics Employees
GlycoMimetics had 35 employees as of December 31, 2023. The number of employees decreased by 4 or -10.26% compared to the previous year.
Employees
35
Change (1Y)
-4
Growth (1Y)
-10.26%
Revenue / Employee
$286
Profits / Employee
-$1,065,050
Market Cap
18.27M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Aspira Women's Health | 64 |
| Cara Therapeutics | 55 |
| Biotricity | 55 |
| MEI Pharma | 46 |
| Kala Pharmaceuticals | 43 |
| iBio, Inc. | 26 |
| Aeterna Zentaris | 12 |
| Indaptus Therapeutics | 7 |
GLYC News
- 6 weeks ago - GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) - Business Wire
- 7 weeks ago - GlycoMimetics to Host Key Opinion Leader Event to Review Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) on June 4, 2024 - Business Wire
- 2 months ago - GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) - Business Wire
- 3 months ago - GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024 - Business Wire
- 4 months ago - GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023 - Business Wire
- 4 months ago - GlycoMimetics to Report Fourth Quarter and 2023 Full Year Financial Results on March 27, 2024 - Business Wire
- 5 months ago - GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference - Business Wire
- 5 months ago - GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Business Wire